Description de l'entreprise
Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases.
Conseil d'administration & Conseil de surveillance
| PDG |
| Robert Koremans |
| Conseil d'administration |
| Andrea Recordati, Giampiero Mazza, Guido Guidi, Joanna Le Couilliard, Michaela Castelli, Piergiorgio Peluso, Cathrin Petty, Giorgio De Palma, Elisa Corghi, Luigi La Corte, Kim Stratton |
| Conseil de surveillance |
| Antonio Santi, Andrea Balelli, Ezio Simonelli, Livia Amidani Aliberti, Patrizia Oriundi Paleologo, Emiliano Nitti , Marco Antonio Viganò |
Données de l'entreprise
| Nom: |
Recordati S.p.A. |
| Adresse: |
via M. Civitali 1,I-20148 Milano |
| Téléphone: |
+39-02-48787-1 |
| Fax: |
+39-02-40073-747 |
| Courriel: |
-
|
| Internet: |
www.recordati.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
46.40% |
| IPO date: |
01/01/1984 |
Relations avec les investisseurs
| Nom: |
Marianne Tatschke |
| Téléphone IR: |
- |
| IR-Fax: |
+39-02-48787-225 |
| E-mail IR: |
inver@recordati.it
|
